Investor relations

Novamind Inc.

Share capitalization
Issued & outstanding: 40,200,767
Reserved for issuance: 7,887,792

Press releases

Former LifeLabs COO Joins Novamind Leadership Team

January 19, 2021

Novamind Expands Psychedelic Medicine Access in Utah

January 13, 2021

Novamind Appoints Chuck Rifici to its Board of Directors

January 08, 2021

Novamind to Commence Trading (CSE:NM) on January 5, 2021

January 04, 2021

Year	Quarter	Date	Report	Download
2020	Q4	December 31, 2020	Filing Statement	View PDF
2020	Q4	November 12, 2020	Material Change Report	View PDF
2020	Q3	July 3, 2020	Material Change Report	View PDF

Filing Statement

December 31, 2020

Q4 • 2020

Material Change Report

November 12, 2020

Q4 • 2020

Material Change Report

July 3, 2020

Q3 • 2020

To view Novamind's full financial disclosures, please visit SEDAR

Transfer agent

Marrelli Trust Company Limited

Legal Counsel

McMillan LLP

Auditor

DMCL LLP

Interested in investing?